Literature DB >> 15593366

Cardiac risk factor awareness and management in patients with systemic lupus erythematosus.

Karen H Costenbader1, Elizabeth Wright, Matthew H Liang, Elizabeth W Karlson.   

Abstract

OBJECTIVE: To assess awareness and management of traditional cardiac risk factors (CRFs) in patients with systemic lupus erythematosus (SLE) and physicians.
METHODS: SLE patients (n=110) completed a questionnaire concerning CRFs. Medical records were reviewed blinded to questionnaire results for the presence and management of 6 CRFs: hypertension, hypercholesterolemia, smoking, obesity, diabetes mellitus, and physical inactivity.
RESULTS: Subjects were predominantly female (97%), mean (+/-SD) age was 43.4 years (+/-11.8), mean SLE duration was 15.3 years (+/-7.2), and 51% had > or =2 CRFs by self report. Twenty-three percent had never had their cholesterol levels checked. Hypercholesterolemia was more frequently documented in the medical records than reported by the patient (33% versus 24%). Physical inactivity was more frequently self reported than documented (59% versus 23%). Rheumatologists and patients had low interrater reliability for the presence of hypercholesterolemia (kappa=0.26) and physical inactivity (kappa=-0.02). More than half (58%) of CRFs were treated, and 21% of subjects with elevated cholesterol received a medication.
CONCLUSION: Recognition, recording, and management of CRFs falls short given the significance of the problem.

Entities:  

Mesh:

Year:  2004        PMID: 15593366     DOI: 10.1002/art.20824

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Clin Rheumatol       Date:  2018-06-12       Impact factor: 2.980

2.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

3.  Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population.

Authors:  Sarah K Chen; Medha Barbhaiya; Michael A Fischer; Hongshu Guan; Tzu-Chieh Lin; Candace H Feldman; Brendan M Everett; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-01       Impact factor: 4.794

4.  Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry.

Authors:  Kathleen Maksimowicz-McKinnon; Faith Selzer; Susan Manzi; Kevin E Kip; Suresh R Mulukutla; Oscar C Marroquin; Thomas C Smitherman; Lewis H Kuller; David O Williams; Mary Chester M Wasko
Journal:  Circ Cardiovasc Interv       Date:  2008-12       Impact factor: 6.546

Review 5.  Atherosclerosis and inflammation: insights from rheumatoid arthritis.

Authors:  Cecilia P Chung; Ingrid Avalos; Paolo Raggi; C Michael Stein
Journal:  Clin Rheumatol       Date:  2007-02-02       Impact factor: 3.650

6.  Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus.

Authors:  Ajax M Atta; João Paulo C G Silva; Mittermayer B Santiago; Isabela S Oliveira; Rodrigo C Oliveira; Maria Luiza B Sousa Atta
Journal:  Clin Rheumatol       Date:  2018-03-08       Impact factor: 3.650

7.  Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.

Authors:  Seong Kyu Kim; Jung Yoon Choe; Shin Seok Lee
Journal:  Yonsei Med J       Date:  2018-09       Impact factor: 2.759

8.  Kinesiophobia and related factors in systemic lupus erythematosus patients

Authors:  Songül Bağlan Yentür; Saliha Karatay; Deran Oskay; Abdurrahman Tufan; Hamit Küçük; Şeminur Haznedaroğlu
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

Review 9.  The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.

Authors:  Dori Abel; Stacy P Ardoin; Mark Gorelik
Journal:  Pediatr Rheumatol Online J       Date:  2021-02-16       Impact factor: 3.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.